6th Annual Precision Medicine Symposium: An Illustrated Tumor Board 

Registration and Breakfast

Personalizing Treatment with EGFR-Targeted Therapies in Metastatic NSCLC

What You Need to Know About Emerging Biomarkers in Metastatic NSCLC

Illustrated Tumor Board - Applying Precision Medicine to Challenging Lung Cancer Cases from the Community

Hot Seat - How Are You Tackling the Logistical Hurdles of Biomarker Testing in Your Clinic?

Introduction of Plenary Presentation Speaker

Plenary Presentation - Innovations and Ethical Considerations for Artificial Intelligence in Cancer Care

Evaluating the Current and Future Role of MRD Testing in MM

Incorporating CAR-T and Bispecifics into the Clinic: Today and Tomorrow

Medical Crossfire: Should We Treat Smoldering Myeloma?

Personalizing Therapy for Early-Stage HR+ Breast Cancer with Genomic Assays

Expanding Role of Precision Medicine in HR+ Metastatic Breast Cancer

Medical Crossfire: Optimizing ADC Sequencing in HER2-Low Metastatic Breast Cancer

How to Manage Your Oncology Practice: Key Insights from Local Leaders

Managing Aggressive DLBCL with Novel Therapies

Illustrated Tumor Board - Applying Precision Medicine to Challenging Lymphoma Cases from the Community

The Emerging Role of PSMA-PET in the Diagnosis and Management of Prostate Cancer

New Directions in Renal Cell Cancer: How Ongoing Trials of Targeted Therapies and Biomarker-Based Approaches Are Addressing Clinical Gaps

Incorporating Novel Treatment Approaches Into Existing Paradigms for the Management of Non-Muscle Invasive Bladder Cancer

Optimizing Individualized Treatment Plans for Patients with Cholangiocarcinoma

Medical Crossfire: Precision Medicine in Colorectal Cancer - Is It Ready for Primetime?